Uehara, Koki
Tanoue, Kenro
Yamaguchi, Kyoko
Ohmura, Hirofumi
Ito, Mamoru
Matsushita, Yuzo
Tsuchihashi, Kenji
Tamura, Shingo
Shimokawa, Hozumi
Isobe, Taichi
Shibata, Yoshihiro
Ariyama, Hiroshi
Tanaka, Risa
Kusaba, Hitoshi
Yamamoto, Hidetaka
Oda, Yoshinao
Akashi, Koichi
Baba, Eishi
Funding for this research was provided by:
Japan Society for the Promotion of Science (JP20K08311)
Article History
Received: 1 February 2023
Accepted: 20 July 2023
First Online: 7 August 2023
Declarations
:
: KTa received honoraria from Ono Pharmaceutical. KY received honoraria from Ono Pharmaceutical and Chugai Pharmaceutical. HO received honoraria from Chugai Pharmaceutical. YM received honoraria from Kyowa Kirin. KTu received Ono Pharmaceutical and Taiho Pharmaceutical. ST received honoraria from Bayer, Ono Pharmaceutical, Chugai Pharmaceutical, Eli Lilly, Merck, Daiichi-Sankyo, LSI Medience, and MSD. HS received honoraria from Ono Pharmaceutical, Eli Lilly, Merck. YS received honoraria from Eli Lilly, Daiichi-Sankyo and Kyowa Kirin. HK received honoraria from Chugai Pharmaceutical. HY received honoraria from AstraZeneca, Bayer, Chugai Pharmaceutical Novartis Pharmaceutical. KA received honoraria from BMS, Ono Pharmaceutical, Janssen Pharmaceutical, Chugai Pharmaceutical, Kyowa Kirin, AbbVie GK, and Eisai; and research grants from Chugai Pharmaceutical, Kyowa Kirin, AbbVie GK, Asahi-Kasei, and Takeda Pharmaceutical. EB received honoraria from Ono Pharmaceutical, Chugai Pharmaceutical, Eli Lilly, Taiho Pharmaceutical, Merck, Sanofi, MSD, Eisai, and Daiichi-Sankyo; and research grants from Taiho Pharmaceutical, Chugai Pharmaceutical, and Eli Lilly. The other authors have no competing interests.
: This study was approved by the Ethical Committee of Kyushu University Hospital (no. 29-348). Written informed consent was obtained from all patients prior to enrollment in the study.
: Not required.